Drug

Extended Release Metformin Hydrochloride clinical trials

A product of Metformin; its studies count on that page too.

studies test it: 12
open now: 1
in phase 3: 2
first study started: 2003

Keep track of what changes. Save the Extended Release Metformin Hydrochloride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Glucophage XR: 8
Glumetza: 8
Extended Release Metformin Hydrochloride: 5
ER Metformin Hydrochloride: 5
Extended-release Metformin Hydrochloride: 5

Studies by the year they started

12 studies that test it; most in 2014 (4)

Studies that test Extended Release Metformin Hydrochloride, by start year
Year	Studies
2003	1
2009	1
2014	4
2018	1
2021	1
2022	1
2023	2
2025	1

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 6
Phase 3: 2

What it is tested for

Each study’s main condition, where its own words name it.

Leukoplakia, Oral: 1
Carcinoma, Intraductal, Noninfiltrating: 1
Lung Neoplasms: 1
Prostatic Neoplasms: 1
Diabetes Mellitus: 1
Obesity: 1

Who runs them

Industry 5 · Other 7

Janssen Research & Development, LLC (3) · Northwestern University (2) · University of Arizona (1) · M.D. Anderson Cancer Center (1) · NYU Langone Health (1) · Merck KGaA, Darmstadt, Germany (1) · AstraZeneca (1) · City of Hope Medical Center (1)

Often tested with

Tested in the same studies.

Canagliflozin (3) · Saxagliptin (1)

Studies

Open first, then newest update. How each study uses Extended Release Metformin Hydrochloride is read from its arms, and is right about nine times in ten.

Testing it · 12

As the comparator · 17 — what is tested is compared with Extended Release Metformin Hydrochloride